ZINZINO AB (PUBL): PRELIMINARY SALES REPORT JULY 2023

Zinzino group revenue increased with a total of 35 %, compared with the previous year.

GOTHENBURG, Sweden, Aug. 3, 2023 /PRNewswire/ — The revenue in July for Zinzino’s sales markets increased by 34 % and amounted to SEK 143.9 (107.2) million. Faun Pharma’s external sales increased by 58 % and amounted to SEK 5.2 (3.3) million. Overall, the Group increased revenues by 35 % to SEK 149.1 (110.5) million compared with the previous year.

Accumulated revenue for January – July 2023 increased by 23 % to SEK 950.9 (774.4) million.

Revenues were distributed as follows:

Regions,MSEK	23-July	22-July	Change	YTD 2023	YTD 2022	Change
The Nordics	22.8	26.4	-14 %	167.5	182.6	-8 %
Central Europe	40.9	22.0	86 %	232.2	145.9	59 %
East Europe	35.1	24.2	45 %	222.1	184.2	21 %
South & West Europe	23.5	13.2	78 %	135.0	87.9	54 %
The Baltics	9.1	5.8	57 %	51.8	40.5	28 %
North America	7.4	6.5	14 %	46.5	39.1	19 %
Asia-Pacific	4.1	8.2	-50 %	34.1	42.5	-20 %
Africa	1.0	0.9	11 %	8.2	4.1	100 %
Zinzino	143.9	107.2	34 %	897.4	726.8	24 %
Faun Pharma	5.2	3.3	58 %	53.5	47.6	12 %
Zinzino Group	149.1	110.5	35 %	950.9	774.4	23 %

Countries in regions:

-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden

–Central Europe: Austria, Germany, Switzerland

–East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania

-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Turkey

-The Baltics: Estonia, Latvia, Lithuania

–North America: Canada, USA

–Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand

–Africa: South Africa